These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 22570947)

  • 1. Autoimmune thyroid disease and allergic contact dermatitis: two immune-related pathologies in the same patient.
    Niedziela M; Bluvshteyn-Walker S
    J Pediatr Endocrinol Metab; 2012; 25(1-2):31-2. PubMed ID: 22570947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Thyroid echogeneity as a useful tool for the differential diagnosis of hyperthyroidism in the course of Graves disease and Hashimoto thyroiditis].
    Niedziela M; Warzywoda M; Korman E
    Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2000; 6(2):143-50. PubMed ID: 12818076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Three patients who spontaneously developed persistent hypothyroidism during or following treatment with antithyroid drugs for Graves' hyperthyroidism.
    Shigemasa C; Mitani Y; Taniguchi S; Adachi T; Ueta Y; Urabe K; Miyazaki S; Tanaka T; Yoshida A; Mashiba H
    Arch Intern Med; 1990 May; 150(5):1105-9. PubMed ID: 1691909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Administration of thyroxine in treated Graves' disease. Effects on the level of antibodies to thyroid-stimulating hormone receptors and on the risk of recurrence of hyperthyroidism.
    Hashizume K; Ichikawa K; Sakurai A; Suzuki S; Takeda T; Kobayashi M; Miyamoto T; Arai M; Nagasawa T
    N Engl J Med; 1991 Apr; 324(14):947-53. PubMed ID: 1900575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High serum osteoprotegerin levels in patients with hyperthyroidism: effect of medical treatment.
    Amato G; Mazziotti G; Sorvillo F; Piscopo M; Lalli E; Biondi B; Iorio S; Molinari A; Giustina A; Carella C
    Bone; 2004 Sep; 35(3):785-91. PubMed ID: 15336617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Macro- and microadenoma of thyrotropin secreting pituitary tumors--two clinical cases.
    Hubalewska-Hola A; Fröss K; Kostecka-Matyja M; Sowa-Staszczak A; Szybiński Z; Huszno B; Ptak M
    Przegl Lek; 2003; 60(11):768-71. PubMed ID: 15058054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Late manifestation of subclinical hyperthyroidism after goitrogenesis in an index patient with a N670S TSH receptor germline mutation masquerading as TSH receptor antibody negative Graves' disease.
    Schaarschmidt J; Paschke S; Özerden M; Jäschke H; Huth S; Eszlinger M; Meller J; Paschke R
    Horm Metab Res; 2012 Dec; 44(13):962-5. PubMed ID: 22763653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methimazole-induced cholestatic jaundice in an elderly hyperthyroid patient.
    Ramos-Bonner LS; Goldberg TH; Moyer S; Anastasopoulou C
    Am J Geriatr Pharmacother; 2007 Sep; 5(3):236-40. PubMed ID: 17996663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucagon binding autoantibodies in a patient with hyperthyroidism treated with methimazole.
    Sanke T; Kondo M; Moriyama Y; Nanjo K; Iwo K; Miyamura K
    J Clin Endocrinol Metab; 1983 Dec; 57(6):1140-4. PubMed ID: 6355138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of methimazole on warfarin anticoagulation in a case of Graves' disease.
    Akin F; Yaylali GF; Bastemir M; Yapar B
    Blood Coagul Fibrinolysis; 2008 Jan; 19(1):89-91. PubMed ID: 18180622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effects of various contraceptives on laboratory parameters in diagnosis of thyroid gland function with special reference to the free hormones FT4 and FT3].
    Sorger D; Schenk S; Schneider G
    Z Gesamte Inn Med; 1992 Feb; 47(2):58-64. PubMed ID: 1585690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The clinical and laboratory findings in Graves' multinodular type disease].
    Grammaticos P; Vasiliou O; Papanastasiou E; Gerasimou G; Balaris V; Alexandris R; Liaros G; Dedousi E
    Hell J Nucl Med; 2006; 9(1):53-9. PubMed ID: 16617399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sustained control of Graves' hyperthyroidism during long-term low-dose antithyroid drug therapy of patients with severe Graves' orbitopathy.
    Laurberg P; Berman DC; Andersen S; Bülow Pedersen I
    Thyroid; 2011 Sep; 21(9):951-6. PubMed ID: 21834677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Severe neutropenia as an adverse effect of methimazole in the treatment of hyperthyroidism.
    Ryan JA
    Clin Excell Nurse Pract; 1999 Jan; 3(1):2-6. PubMed ID: 10476084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methimazole protection against oxidative stress induced by hyperthyroidism in Graves disease.
    Sewerynek J; Wiktorska J; Nowak D; Lewinski A
    Endocr Regul; 2000 Jun; 34(2):83-9. PubMed ID: 10911409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoimmune thyroiditis and myelosuppression following treatment with interferon-alpha for hepatitis C.
    Schmitt K; Hompesch BC; Oeland K; von Staehr WG; Thürmann PA
    Int J Clin Pharmacol Ther; 1999 Apr; 37(4):165-7. PubMed ID: 10235418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antineutrophil cytoplasmic antibody (ANCA)-associated autoimmune diseases induced by antithyroid drugs: comparison with idiopathic ANCA vasculitides.
    Bonaci-Nikolic B; Nikolic MM; Andrejevic S; Zoric S; Bukilica M
    Arthritis Res Ther; 2005; 7(5):R1072-81. PubMed ID: 16207324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment of hyperthyroidism in children with antithyroid drugs].
    Thibault H; Clausse-Moysoulier D; Brauner R
    Ann Pediatr (Paris); 1993 Jun; 40(6):341-7. PubMed ID: 8352494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methimazole-Induced Goitrogenesis in an Adult Patient With the Syndrome of Resistance to Thyroid Hormone.
    Glymph K; Gosmanov AR
    J Investig Med High Impact Case Rep; 2014; 2(4):2324709614555768. PubMed ID: 26425626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Monosymptomatic hyperthyroidism and TSH-producing adenoma: successful therapy with octreotide].
    Mayinger B; Axelos D; Pavel M; Hahn EG; Hensen J
    Dtsch Med Wochenschr; 1999 Jan; 124(4):73-8. PubMed ID: 10071603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.